with idiopathic hypercalciuria (IH) (1049 males and 307 females). We excluded uric acid and infection stones containing struvite. Results. Calcium oxalate (CaOx) was the most prevalent crystalline species among the main components of stones in all groups. However, CaOx stones were significantly less frequent in patients with vs without HPT (51.9% vs 82.2%; P < 0.0001). An inversion of CaOx crystalline phases was observed in HPT and IH patients: whewellite was predominant in 16.3% and 30.2% of cases, respectively, vs 57.4% in the non-HPT group (P < 0.001), whereas weddellite was predominant in 35.6% of HPT and 49.5% of IH vs 24.8% of non-HPT stones (P < 0.0001). Among calcium phosphates, brushite was 7-fold more frequent in HPT than in non-HPT patients (14.0% vs 2.2%; P < 0.0001) and almost three times as frequent as in IH patients (4.9%, P < 0.0001). Carbapatite was significantly more frequent in male patients with HPT vs non-HPT or IH patients (23.1% vs 8.3% and 9.9%, P < 0.0001). Morphological data showed that pure type I calculi were markedly less frequent in HPT patients (1.1% vs 25.3% in non-HPT group, P < 0.0001, and 9.1% in IH subgroup, P < 0.001). A high occurrence of IVd calculi and of the association of types IVa and II was observed in HPT vs non-HPT and IH patients (14.4%, 2.3% and 6.3%, P < 0.0001 and 58.3%, 17.2% and 29.9%, P <
Introduction
The renal manifestations of primary hyperparathyroidism (HPT) include recurrent nephrolithiasis, nephrocalcinosis and impaired renal function [1, 2] . Over the last decades, the epidemiology of HPT has undergone marked changes. This endocrine disease typically affects elderly women, and it is infrequent in childhood [2] [3] [4] . HPT can occur at any age, but it is most commonly seen in the middle-aged population. Epidemiological studies agree with a prevalence ranging from 1 to 4/1000 in the general population [5] [6] [7] . Approximately 100 000 new cases are diagnosed each year in the USA [3] . Gender difference was documented by Bilezikian et al. who reported a female predominance of more than 3:1 with a prevalence peaking between the ages of 50 and 60 years [3] . In women aged 55-75 years, the prevalence was estimated at 3/1000 in the general population in Europe [2] . As recently underlined by Fraser [8] , >70% of patients with HPT have no obvious symptoms or signs of the disease, which is detected by an incidental finding of hypercalcaemia. The prevalence of HPT among stone formers ranged from 1.8% to 6.6% [9] [10] [11] [12] [13] . Recently, Suh et al. found that the prevalence of renal stones in HPT patients increased 4-fold compared with non-HPT patients [14] .
However, to the best of our knowledge, only two studies have evaluated stone composition in HPT stone formers. Among 1392 patients with both a medical diagnosis and a stone analysis, Pak et al. found that HPT accounted for 2% of calcium oxalate (CaOx) stones and 10% of apatite stones, the former being defined as stones containing at least 70% calcium oxalate and the latter containing at least 30% of apatite [11] . The authors concluded that stone analysis did not significantly aid the aetiology. More recently, Parks et al. [12] reviewed the clinical and laboratory characteristics of their cohort of stone formers including 2416 patients, among them 105 having HPT. They found that stones associated with HPT had a higher content of calcium phosphate (CaP) in male patients only. Crystalline phases were not considered in this study. Taking advantage of stones referred to our laboratory for analysis, we analysed the relationship between HPT and crystalline phases and morphology of calculi in order to seek biomarkers in stones which are suggestive of this endocrine disease.
Materials and methods
From 1 January 1990 to 31 March 2009, calculi from 267 HPT patients (144 males and 123 females) and 24 567 non-HPT stone formers (16 918 males and 7649 females) matched for age (mean ± SD, 47.7 ± 16.3 vs 47.5 ± 15.7 years) were referred to our laboratory for analysis. Included in this study were calculi from patients for whom information on HPT status had been provided. We excluded three HPT patients presenting with either uric acid stone or infectious stone mainly composed of struvite. All HPT patients were diagnosed on the basis of either a high level of serum parathormone despite hypercalcaemia or an inadequate response of parathormone after calcium load. In all cases, primary hyperparathyroidism was confirmed by cervicotomy. Due to the high prevalence of hypercalciuria in HPT patients, we also compared composition and morphology of stones developed in HPT patients with those observed in a subgroup of non-HPT subjects including 1356 hypercalciuric (IH) patients (1049 males and 307 females) without HPT. Hypercalciuria was defined as a urinary calcium excretion >0.1 mmol/kg/day in both sexes. Thus, we assessed the respective influence of hypercalciuria and HPT on the stone characteristics.
We excluded from this study stones of genetic origin such as cystine stones, primary hyperoxaluria stones, 2,8-dihydroxyadenine and also drug-induced stones, all of them depending on specific factors. As for HPT patients, we also excluded uric acid stones and infections stones containing struvite.
Each stone was analysed, and its morphological type was defined according to our previously published protocol [15] . Briefly, each stone was first examined under stereomicroscope for recording its morphological characteristics of both surface and section. Thereafter, according to the superficial and inner structure (Figure 1 ), the stone was classified using the proposed morphological classification of stones, which includes 6 types and 23 subtypes, summarized in Table 1 . The second step of stone analysis was a sequential identification of components from the core to the surface, based on a selection of samples from each area of interest (core, layers and surface). Each sample was analysed by Fourier transform infrared spectroscopy (FTIRS) as previously described [16] . Finally, a representative part of the stone was powdered and analysed by FTIRS for quantifying relative proportions of each component identified by sequential analysis.
Statistical analysis
Results are given as percentages or as means ± SEM. Categorical comparisons were performed using the chi-square test. Numeric variables were compared using ANOVA. Data analysis was performed with the NCSS statistical package (J. Hintz, Gainesville, FL, USA).
Results
The distribution of the main components of stones in males and females of each group is shown in Table 2 . The male-tofemale ratio differs between the groups (1.18 for HPT group, 2.21 for non-HPT group and 3.42 for IH patients; P < 0.0001). CaOx was most prevalent as the main component of stones in all groups. However, the proportion of CaOx stones was significantly lower in patients with HPT when compared with the other groups (51.9% vs 82.2% for non-HPT and 79.7% for IH patients; P < 0.0001). Among CaOx stones, whewellite was the main component in 16.3% and 30.2% of cases in HPT and IH patients, respectively, vs 57.4% in the non-HPT group (P < 0.001), whereas weddellite, a typically calcium-dependent crystalline species, was the preponderant component in 35.6% of HPT and 49.5% of IH vs 24.8% of non-HPT stones (P < 0.0001). Interestingly, brushite, another calcium-dependent crystalline species, was 7-fold more frequent as main component in HPT than in non-HPT patients (14.0% vs 2.2%; P < 0.0001). Taking into account the two main components of a stone, the prevalence of brushite in HPT was 17.0% vs 2.4% (P < 0.0001) in non-HPT and 6.4% in IH patients (P < 0.0001). There was a significant difference in stone composition between genders in the HPT group: CaOx stones were more frequent in males (59.4% vs 43.0%, P < 0.01), and CaP stones were more frequent in females (57.0% vs 40.6% in males, P < 0.01). Of note, carbapatite was the main component of 43% of stones in female HPT patients vs 23.1% in their male counterparts (P < 0.001). Finally, stones mainly composed of carbapatite were significantly more frequent in men with HPT vs non-HPT (8.3%, P < 0.0001) or IH (9.9%; P < 0.0001). Another striking point was the mean content of each crystalline phase in stones (Table 3 ). In CaOx-containing stones, the mean content of CaOx in males and females was, respectively, 56.7% and 48.1% in HPT group vs 78.5% and 69.0% in non-HPT group (P < 0.0001); specifically, whewellite was less preponderant in males and females with HPT (21.0% and 18.7%, respectively, vs 55.4% and 52.8% in non-HPT group; P < 0.0001), while no difference was observed for weddellite. In IH patients, the CaOx content was similar to that observed for non-HPT subjects. However, due to the higher content of weddellite in this group, both whewellite and weddellite were significantly more abundant in IH than in HPT patients. Conversely, in CaP-containing stones, an increased proportion of carbapatite was observed in the HPT group in comparison with non-HPT or IH patients in male (28.2% vs 11.3% in non-HPT and 15.3% in IH, P < 0.0001) and female patients as well (37.6% vs 22.7% in non-HPT, P < 0.0001, and 28.6% in IH, P < 0.01). In contrast, no difference was found regarding the brushite content between HPT, non-HPT and IH patients.
Our results based on morphological data provide evidence that strong differences exist in the distribution of the morphological stone types according to the aetiology (Table 4) . While whewellite was only two or three times less frequent as main component of the stones in HPT vs IH or non-HPT patients (see Table 2 ), pure type I calculi were markedly less frequent in HPT patients (1.1% vs 25.3% in non-HPT group; P < 0.0001). In the case of hypercalciuria, pure type I accounted for 9.1% of the stones (P < 0.001 vs HPT). Pure type II stones were significantly less frequent in HPT than in IH patients (6.4% vs 18.7%, P < 0.0001). The highest frequency of type IVd stones was observed in the HPT vs non-HPT group (14.4% vs 2.3%; P < 0.0001). Intermediate occurrence was found for IH patients (6.3%, P < 0.0001 vs HPT). The association of types IVa and IIa/b in stone morphology was found in 58.3% in HPT group vs only 17.2% in non-HPT and in 29.9% in IH patients (P < 0.0001) (Figure 2 ).
The stone nucleus was available in 257 calculi from HPT patients. It was made of weddellite or brushite, respectively, in 25.2% and 8.3% of cases in HPT group vs 11.5% and 0.9% in non-HPT group (P < 0.0001) ( Table 5) . Brushite nuclei were more frequent in HPT than in IH patients (8.3% vs 3.5%, P < 0.01), while the occurrence of weddellite nuclei was similar in both groups. Another important finding was the very low occurrence of stones developed from a Randall's plaque in HPT as compared with non- HPT patients (2.8% vs 23.9%; P < 0.0001). In IH patients, Randall's plaque was found as the initial step occurring during the stone formation in 14.2% of cases (P < 0.0001 by comparison with the HPT group). Finally, significant differences exist between HPT and IH patients, regarding the proportion of weddellite or whewellite stones, calcium phosphate stones, especially brushite or carbapatite, and stone morphology. Interestingly, whewellite-to-weddellite ratio was not different between HPT and IH patients (Table 6 ). In contrast, CaOx-to-CaP ratio, as expected, was significantly lower in HPT than in IH patients, the highest difference being observed for the whewellite/carbapatite ratio ( Figure 3) .
Discussion
There is a paucity of published literature on the impact of HPT on stone composition and morphology. To our knowledge, this is the first study comparing the distribution of stone components and morphology in stones formers with or without HPT.
We and others [17, 18] previously reported the preponderance of males among urinary stone formers [19] . Such preponderance was observed in the three groups in this series but was significantly lower in HPT group. This is in agreement with the higher occurrence of HPT in women, as reported by Bilezikian et al. who found a 3:1 female-to-male ratio [3] . Several studies agree that hypercalciuria, hyperphosphaturia and high urine pH could represent some risk factors for urolithiasis in HPT patients [20, 21] . Based on a small series of 32 HPT patients, Pak et al. concluded that there were many pathophysiological backgrounds for lithogenic mechanisms in HPT [22] . Recent papers showed that there is actually no difference in metabolic profile between HPT stone formers vs HPT stone-free subjects. They concluded that it is impossible to predict which patients with HPT will develop urolithiasis [23, 24] . In another study conducted to identify metabolic abnormalities differentiating HPT stone formers from those remaining stone free, Odvina et al. found that stone formers with HPT have more severe hypercalciuria due to intestinal hyperabsorption of calcium [21] . On the other hand, it has been reported that an increase in urinary pH occurs in HPT, and this enhances the formation of crystalline calcium phosphate species [20] . The higher CaP content in stones from HPT patients is in agreement with this finding.
The results of our study demonstrate that there were significant differences in stone composition between HPT and non-HPT stone formers and also between HPT and IH patients. CaP stones are believed to be the most common type of stones in HPT patients [11] . In our study, we found that CaOx stones are the most prevalent in HPT and in non-HPT patients as well. The same was observed in the IH subgroup. However, we confirmed the markedly higher proportion of CaP stones in the HPT group especially in males as reported recently by Parks et al. [12] . In their study, the authors did not distinguish the crystalline phases of CaP because of the small size of their series. Based on a large series of calculi, our data provide epidemiologic evidence that HPT is associated with an increased risk of calcium-dependent crystalline species formation, especially brushite and weddellite [25] [26] [27] . In idiopathic hypercalciuria, which is another metabolic condition for crystallization of calciumdependent crystalline species, we found that brushite was more frequent than in non-HPT patients, but less than in stones developed by HPT patients. In contrast, weddellite was the main crystalline phase of almost 50% of stones. Another finding was the CaP content of stones, which was significantly lower in IH than HPT patients.
HPT stone formers have a strikingly lower occurrence of stones developed from a Randall's plaque when compared with either common stone formers or IH patients. These data suggest that Randall's plaque, which was reported in the recent years as a major cause of calcium stone formation in western countries [28] [29] [30] , plays a minor role, if any, in the formation of calcium stones in the case of primary hyperparathyroidism. The very high occurrence of Randall's plaques in most calcium oxalate stone formers as reported in the USA [29, 31] could explain the recent observation by Evan et al. [32] of the concomitant presence of Randall's plaques and plugs of calcium phosphate in tubules of HPT patients. The significant difference found in our series as to the occurrence of Randall's plaque in stones from HPT and IH patients suggests that the lithogenic conditions involved in stone formation are at least partly different between these two groups of patients. Of interest is the composition of the stone nucleus. As observed in Table 5 , carbapatite was the main component of stone nuclei in all groups. However, significant differences exist between groups. For example, carbapatite formation was the initiating species of the stone in 65.9% of the non-HPT group, 54.0% in the IH group and only 42.3% in the HPT group, although the CaP content of the stones was significantly higher in that latter group. Conversely, the carbapatite nucleus was a Randall's plaque in 23.9% of stones in the non-HPT group, 14.2% in IH patients and only 2.8% in the case of HPT. Such a difference suggests several origins for apatite: mainly from Randall's plaque in common calcium stones, partly from Randall's plaque and from tubules in IH patients, and mainly from tubules for HPT patients.
Probably pH values that are of major importance for CaP formation and the level of urinary calcium are likely to be important factors modulating stone formation in these different groups of patients. Recently, Worcester et al. [33, 34] provided evidence that a postprandial reduction of renal calcium reabsorption in the proximal tubule could increase calcium delivery in the distal nephron and play a role in hypercalciuric stages of stoneforming patients. As suggested by Evan and co-workers, hypercalciuric states could be crucial in the deposition of calcium phosphate in the interstitium of the inner medulla and could be an important factor for secondary initiating calcium oxalate formation on the plaque emerging at the tip of the papilla. However, our results suggest that the dynamics of crystallization, and perhaps the site of crystal formation, could be different between HPT, non-HPT and IH patients. Unfortunately, no comprehensive biological data from the patients of our series of stones were available to discuss more accurately the lithogenic conditions.
HPT is relatively infrequent in renal stone formers. The incidence of HPTamong patients of whom stones were referred to our laboratory for analysis between January 1991 and March 2009 was 2.4%, which is in agreement with other epidemiological reports [9, [11] [12] [13] . Our data provide evidence that some characteristics of the stones may suggest HPT as a cause of nephrolithiasis. As reported by Pak et al. [11] , HPT was more frequent in stones enriched in apatite, a similar conclusion being deduced from the observation of Parks et al. [12] . Our results are in agreement with these data.
In 1991, the National Institute of Health (NIH) presented a consensus statement on indications for parathyroidectomy [35] . Recommendations were updated in 2009 [36] . In the case of HPT, nephrolithiasis was initially a well-accepted indication for surgery. This criterion has disappeared in the new guidelines for surgery. Hypercalciuria, a frequent finding in patients with primary hyperparathyroidism, is no longer considered an indication for parathyroidectomy, except in the case of nephrolithiasis. In view of the variability of stone composition and morphology which are related to metabolic abnormalities, it seems reasonable to investigate the stone composition and morphology which actually are related to HPT. Our study provides evidence that only calculi mainly composed of brushite or presenting with IVd or IV + II morphology (Figure 2) , which account for 72.7% of all stones in HPT patients vs 19.5% in the non-HPT group (P < 0.0001) and 36.2% in IH patients (P < 0.0001), constitute a potential sign of HPT-related stones.
The literature discloses considerable disagreement on the impact of parathyroidectomy on lithogenic risks [37, 38] . Mollerup et al. [37] showed that after parathyroidectomy, HPT stone formers had a recurrence rate comparable with that observed among patients with idiopathic renal stone disease. In 2002, the same group published that the risk of a new stone event was 8.3% higher in patients than in controls after surgery and that this risk remained higher until more than 10 years after parathyroidectomy [39] .
Conclusions
Renal stone disease in HPT patient is a multifactorial disease, and the relation of HPT with lithogenesis in stone patients is still debated. Our results are highly suggestive that HPT induces stones of peculiar composition or morphological type. Thus, patients who develop calciumdependent crystalline species such as brushite or mixed weddellite plus carbapatite stones with IVd or IV + II morphology should be especially screened for HPT.
Conflict of interest statement. None declared.
